Portola Pharma (PTLA) Tops Q3 EPS by 54c

Portola Pharma (NASDAQ: PTLA) reported Q3 EPS of ($1.08), $0.54 better than the analyst estimate of ($1.62). Revenue for the quarter came in at $14.2 million versus the consensus estimate of $7.1 million.

For earnings history and earnings-related data on Portola Pharma (PTLA) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Aon names interim CFO as Edmund Reese exits the firm
• INVO Fertility (IVF) Tops Q2 EPS by 105c